• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新发PIK3R1功能获得性突变伴反复的鼻窦肺部感染、持续性慢性巨细胞病毒淋巴结炎和小头畸形。

De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephaly.

作者信息

Kuhlen Michaela, Hönscheid Andrea, Loizou Loizos, Nabhani Schafiq, Fischer Ute, Stepensky Polina, Schaper Jörg, Klapper Wolfram, Siepermann Meinolf, Schuster Friedhelm, Meisel Roland, Borkhardt Arndt

机构信息

University of Duesseldorf, Medical Faculty, Department of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Duesseldorf, Germany.

Pediatric Oncology-Hematology Clinic, Archbishop Makarios III Hospital, Nicosia, Cyprus.

出版信息

Clin Immunol. 2016 Jan;162:27-30. doi: 10.1016/j.clim.2015.10.008. Epub 2015 Oct 31.

DOI:10.1016/j.clim.2015.10.008
PMID:26529633
Abstract

PIK3R1 (phosphoinositide-3-kinase, regulatory subunit 1) gain-of-function has recently been described in patients with recurrent sinopulmonary infections, chronic CMV-/EBV-infections, lymphoproliferation, and hypogammaglobulinemia. Here we report a 15-year-old boy with treatment refractory CMV lymphadenitis, severe combined immunodeficiency, microcephaly and a severe developmental defect of Th17 cells. To avoid poor outcome, hematopoietic stem cell transplantation (HSCT) was performed. Subsequently, whole exome sequencing revealed a de novo heterozygous G-to-C mutation (chr5: 5:67,589,663: G>C) at the splice donor site of the PIK3R1 gene. Our data suggest that PIK3R1 gain-of-function leads to developmental defects in helper and regulatory T-cell subsets, the latter expanding the immunological features of PIK3R1 gain-of-function. T-cell subsets play a critical role in the regulation of immune response against infectious agents and of autoimmunity and thus may be particularly accountable for the clinical phenotype of affected patients.

摘要

PIK3R1(磷脂酰肌醇-3-激酶调节亚基1)功能获得性突变最近在患有复发性鼻窦肺部感染、慢性巨细胞病毒/EB病毒感染、淋巴细胞增殖和低丙种球蛋白血症的患者中被发现。在此,我们报告一名15岁男孩,患有治疗难治性巨细胞病毒淋巴结炎、严重联合免疫缺陷、小头畸形以及Th17细胞严重发育缺陷。为避免不良后果,进行了造血干细胞移植(HSCT)。随后,全外显子组测序在PIK3R1基因的剪接供体位点发现了一个新生的杂合G到C突变(chr5: 5:67,589,663: G>C)。我们的数据表明,PIK3R1功能获得性突变导致辅助性和调节性T细胞亚群发育缺陷,后者扩展了PIK3R1功能获得性突变的免疫特征。T细胞亚群在针对感染因子的免疫反应调节和自身免疫中起关键作用,因此可能是受影响患者临床表型的特别原因。

相似文献

1
De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephaly.新发PIK3R1功能获得性突变伴反复的鼻窦肺部感染、持续性慢性巨细胞病毒淋巴结炎和小头畸形。
Clin Immunol. 2016 Jan;162:27-30. doi: 10.1016/j.clim.2015.10.008. Epub 2015 Oct 31.
2
Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome.活化的磷脂酰肌醇-3-激酶-δ 综合征中的疱疹病毒。
Front Immunol. 2018 Feb 23;9:237. doi: 10.3389/fimmu.2018.00237. eCollection 2018.
3
Gain-of-function mutation in PIK3R1 in a patient with a narrow clinical phenotype of respiratory infections.一名患有呼吸道感染狭窄临床表型患者的PIK3R1功能获得性突变
Clin Immunol. 2016 Dec;173:117-120. doi: 10.1016/j.clim.2016.09.011. Epub 2016 Sep 28.
4
6-year-old boy with recurrent sinopulmonary infections and lymphadenopathy.一名患有反复鼻窦肺部感染和淋巴结病的6岁男孩。
J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):461-3.e1; quiz 464-5. doi: 10.1016/j.jaip.2014.10.017.
5
Case Report: Hodgkin Lymphoma and Refractory Systemic Lupus Erythematosus Unveil Activated Phosphoinositide 3-Kinase-δ Syndrome 2 in an Adult Patient.病例报告:成人患者中霍奇金淋巴瘤与难治性系统性红斑狼疮揭示活化磷脂酰肌醇3-激酶δ综合征2型
Front Pediatr. 2021 Jul 8;9:702546. doi: 10.3389/fped.2021.702546. eCollection 2021.
6
Early diagnosis of PI3Kδ syndrome in a 2 years old girl with recurrent otitis and enlarged spleen.2 岁女童反复中耳炎伴脾大,提示早发型 PI3Kδ 综合征
Immunol Lett. 2017 Oct;190:279-281. doi: 10.1016/j.imlet.2017.08.021. Epub 2017 Aug 31.
7
Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K.PIK3R1 杂合剪接突变导致人类免疫缺陷伴淋巴组织增生,原因是 PI3K 的显性激活。
J Exp Med. 2014 Dec 15;211(13):2537-47. doi: 10.1084/jem.20141759. Epub 2014 Dec 8.
8
The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS).伊朗首个人群小儿活化磷酯酰肌醇 3-激酶 δ 综合征(APDS)队列研究。
Immunol Invest. 2022 Apr;51(3):644-659. doi: 10.1080/08820139.2020.1863982. Epub 2021 Jan 6.
9
PIK3R1 Mutation Associated with Hyper IgM (APDS2 Syndrome): A Case Report and Review of the Literature.与高IgM相关的PIK3R1突变(APDS2综合征):一例病例报告及文献综述
Endocr Metab Immune Disord Drug Targets. 2019;19(7):941-958. doi: 10.2174/1871530319666190225114739.
10
Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome.活化的磷酯酰肌醇 3-激酶 δ 综合征的呼吸表现。
Front Immunol. 2018 Mar 5;9:338. doi: 10.3389/fimmu.2018.00338. eCollection 2018.

引用本文的文献

1
Systematic literature reviews to identify epidemiological, clinical, economic and health-related quality of life evidence in activated PI3Kδ syndrome (APDS).系统性文献综述,以识别活化磷脂酰肌醇-3-激酶δ综合征(APDS)的流行病学、临床、经济和健康相关生活质量证据。
BMC Immunol. 2025 Jul 19;26(1):52. doi: 10.1186/s12865-025-00723-6.
2
Overall survival among patients with activated phosphoinositide 3-kinase delta syndrome (APDS).活化磷脂酰肌醇3-激酶δ综合征(APDS)患者的总生存期。
Orphanet J Rare Dis. 2025 May 3;20(1):212. doi: 10.1186/s13023-025-03734-z.
3
Exploring Monogenic, Polygenic, and Epigenetic Models of Common Variable Immunodeficiency.
探索常见可变免疫缺陷的单基因、多基因和表观遗传模型。
Hum Mutat. 2025 Apr 15;2025:1725906. doi: 10.1155/humu/1725906. eCollection 2025.
4
Hyperactivation of the PI3K pathway in inborn errors of immunity: current understanding and therapeutic perspectives.免疫缺陷病中PI3K信号通路的过度激活:当前认识与治疗前景
Immunother Adv. 2024 Nov 7;4(1):ltae009. doi: 10.1093/immadv/ltae009. eCollection 2024.
5
Genetic Etiologies and Outcomes in Malignancy and Mortality in Activated Phosphoinositide 3-Kinase Delta Syndrome: A Systematic Review.活化磷脂酰肌醇3-激酶δ综合征的遗传病因与恶性肿瘤及死亡率的结局:一项系统综述
Adv Ther. 2025 Feb;42(2):752-771. doi: 10.1007/s12325-024-03066-7. Epub 2024 Dec 5.
6
Systematic review of mortality and survival rates for APDS.APDS 死亡率和生存率的系统评价。
Clin Exp Med. 2024 Jan 27;24(1):17. doi: 10.1007/s10238-023-01259-y.
7
Control of CD4 T Cell Differentiation and Function by PI3K Isoforms.PI3K 同工型对 CD4 T 细胞分化和功能的调控。
Curr Top Microbiol Immunol. 2022;436:197-216. doi: 10.1007/978-3-031-06566-8_8.
8
Influence of the detection of parent-of-origin on the pregnancy outcomes of fetuses with copy number variation of unknown significance.父源检测对意义不明拷贝数变异胎儿妊娠结局的影响。
Sci Rep. 2020 Jun 1;10(1):8864. doi: 10.1038/s41598-020-65904-2.
9
Activated phosphoinositide 3-kinase delta syndrome 1 and 2 (APDS 1 and APDS 2): similarities and differences based on clinical presentation in two boys.活化磷脂酰肌醇3激酶δ综合征1型和2型(APDS 1和APDS 2):基于两名男孩临床表现的异同
Allergy Asthma Clin Immunol. 2020 Apr 1;16:22. doi: 10.1186/s13223-020-00420-6. eCollection 2020.
10
An updated review on activated PI3 kinase delta syndrome (APDS).关于活化磷脂酰肌醇-3激酶δ综合征(APDS)的最新综述。
Genes Dis. 2019 Oct 14;7(1):67-74. doi: 10.1016/j.gendis.2019.09.015. eCollection 2020 Mar.